PubMed · 15366193
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Mike Boggild, Helen Ford. 2003. Multiple sclerosis.. https://pubmed.ncbi.nlm.nih.gov/15366193/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The armamentarium of medications for the treatment of inflammatory bowel disease is growing and becoming more complicated to use. Immunomodulators are a class of medications that have found a niche for the treatment of Crohn's disease and ulcerative colitis. Because of the mounting supporting evidence for efficacy, the most commonly-used immunomodulators are azathioprine, mercaptopurine, methotrexate and ciclosporin. These medications are being used more often due to their steroid-sparing and potentially surgery-sparing effects. Immunomodulators are also known for a significant side-effect profile and require careful monitoring. This review provides the latest information for clinicians on efficacy, side-effects, dosing and monitoring of these medications for treatment of inflammatory bowel disease.
Explore the source record for details and available documents.
Explore the source record for details and available documents.